Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Network is a biotechnology company focused on revolutionizing drug discovery through the application of network biology and advanced computational modeling. By mapping the complex web of molecular interactions within cells, the company identifies novel therapeutic targets and predicts drug efficacy with higher precision than traditional methods. Their platform integrates high-throughput multi-omics data to simulate disease states and therapeutic interventions in silico. Network primarily focuses on developing treatments for complex diseases, including oncology and rare genetic disorders, where traditional single-target approaches have historically failed. The company aims to accelerate the transition from target identification to clinical validation by leveraging its proprietary systems biology insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Network.